Can increased stool triglycerides with normal pancreatic elastase point to bile acid dysfunction instead of pancreatic insufficiency?

In patients presenting with symptoms of fat malabsorption, distinguishing between pancreatic and non-pancreatic etiologies is critical for defining the correct therapeutic pathway, particularly when standard digestive markers yield apparently discordant results.

Clinical differentiation of malabsorption

• Fecal pancreatic elastase-1 (FPE-1) concentrations greater than 200 µg/g possess a high negative predictive value, effectively ruling out moderate-to-severe primary exocrine pancreatic insufficiency (EPI) as the driver of malabsorption.
• When FPE-1 is normal but stool triglycerides remain elevated, the diagnostic focus shifts away from primary pancreatic failure toward upstream pre-pancreatic or luminal digestive processes.

Mechanistic pathways of impaired emulsification

• Efficient lipid digestion requires bile acid-mediated emulsification to assemble dietary fats into mixed micelles, which increases the surface area of triglycerides and makes them accessible to pancreatic lipase.
• When bile acid function is compromised—due to biliary obstruction, bile acid deficiency, or impaired enterohepatic circulation—the mechanical and chemical emulsification of dietary lipids fails.
• Without adequate emulsification, pancreatic lipases cannot effectively hydrolyze the ester bonds of neutral fats, leading directly to an accumulation of unhydrolyzed, neutral triglycerides in the stool and clinical maldigestion.

Bottom line

• Elevated stool triglycerides in the presence of normal fecal pancreatic elastase (>200 µg/g) indicate that fat maldigestion is driven by impaired lipid emulsification or bile acid dysfunction rather than primary pancreatic insufficiency.